| [1] |
Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice[J]. Lancet, 2011, 377(9783):2115-2126.
|
| [2] |
Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis[J]. Nat Rev Rheumatol, 2014, 10(7):437-441.
|
| [3] |
Tang X, Wang SF, Zhan SY, et al. The prevalence of symptomatic knee osteoarthritis in China results from the China health and retirement longitudinal study[J]. Arthritis Rheumatol, 2016, 68(3):648-653.
|
| [4] |
Kang X, Fransen M, Zhang Y, et al. The high prevalence of knee osteoarthritis in a rural Chinese population: the Wuchuan osteoarthritis study[J]. Arthritis Rheum, 2009，61(5):641-647.
|
| [5] |
Zhang JF, Song LH, Wei JN, et al. Prevalence of and risk factors for the occurrence of symptomatic osteoarthritis in rural regions of Shanxi Province, China[J]. Int J Rheum Dis, 2016, 19(8):781-789.
|
| [6] |
Lin J, Fransen M, Kang X, et al. Marked disability and high use of nonsteroidal antiinflammatory drugs associated with knee osteoarthritis in rural China: a cross-sectional population-based survey[J/OL]. Arthritis Res Ther, 2010, 12(6):R225.
|
| [7] |
Hawker GA, Croxford R, Bierman AS, et al. All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study[J/OL]. PLoS One, 2014, 9(3):e91286.doi： 10.1371/journal.pone.0091286. |
| [8] |
Xing D, Xu YK, Liu Q, et al. Osteoarthritis and all-cause mortality in worldwide populations: grading the evidence from a meta-analysis[J/OL]. Sci Rep, 2016, 6:24393.
|
| [9] |
Liu Q, Niu J, Li H, et al. Knee symptomatic osteoarthritis, walking disability, NSAIDs use and all-cause mortality: population-based Wuchuan osteoarthritis study[J/OL]. Sci Rep, 2017, 7(1):3309.
|
| [10] |
Abramson J, Starfield B. The effect of conflict of interest on biomedical research and clinical practice guidelines: can we trust the evidence in evidence-based medicine？[J]. J Am Board Fam Pract, 2005, 18(5):414-418.
|
| [11] |
Pablos-Mendez A, Shademani R. Knowledge translation in global health. J Contin Educ Health Prof, 2006，26(1):81-86.
|
| [12] |
Green LW, Ottoson JM, García C, et al. Diffusion theory and knowledge dissemination, utilization, and integration in public health[J]. Annu Rev Public Health, 2009, 30:151-174.
|
| [13] |
Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition[J]. J Am Acad Orthop Surg, 2013, 21(9):577-579.
|
| [14] |
Xing D, Wang B, Zhang W, et al. Intra-articular platelet-rich plasma injections for knee osteoarthritis: An overview of systematic reviews and risk of bias considerations[J]. Int J Rheum Dis, 2017, 20(11):1612-1630.
|
| [15] |
Dai WL, Zhou AG, Zhang H, et al. Efficacy of Platelet-Rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials[J]. Arthroscopy, 2017, 33(3):659-670.e1.
|
| [16] |
Meheux CJ, Mcculloch PC, Lintner DM, et al. Efficacy of intra-articular Platelet-Rich plasma injections in knee osteoarthritis: a systematic review[J]. Arthroscopy, 2016, 32(3):495-505.
|
| [17] |
Laudy AB, Bakker EW, Rekers M, et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis[J]. Br J Sports Med, 2015, 49(10):657-672.
|
| [18] |
Khoshbin A, Leroux T, Wasserstein D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis[J]. Arthroscopy, 2013, 29(12):2037-2048.
|
| [19] |
Shen LX, Yuan T, Chen SB, et al. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials[J/OL]. J Orthop Surg Res, 2017, 12(1):16. DOI 10.1186/s13018-017-0521-3 |
| [20] |
Kanchanatawan W, Arirachakaran A, Chaijenkij K, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee[J]. Knee Surg Sports Traumatol Arthrosc, 2016, 24(5):1665-1677.
|
| [21] |
Montañez-Heredia E, Irízar S, Huertas PJ, et al. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the Spanish National Health Care System[J/OL]. Int J Mol Sci, 2016, 17(7):E1064. doi: 10.3390/ijms17071064. |
| [22] |
Chang KV, Hung CY, Aliwarga F, et al. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis[J]. Arch Phys Med Rehabil, 2014, 95(3):562-575.
|
| [23] |
Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions[J]. Knee Surg Sports Traumatol Arthrosc, 2010, 18(4):472-479.
|
| [24] |
Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial[J]. Am J Sports Med, 2013, 41(2):356-364.
|
| [25] |
Kavadar G, Demircioglu DT, Celik MY, et al. Effectiveness of platelet-rich plasma in the treatment of moderate knee osteoarthritis: a randomized prospective study[J]. J Phys Ther Sci, 2015, 27(12):3863-3867.
|
| [26] |
Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis[J]. Am J Sports Med, 2012, 40(12):2822-2827.
|
| [27] |
Chen CPC, Cheng CH, Hsu CC, et al. The influence of platelet rich plasma on synovial fluid volumes, protein concentrations, and severity of pain in patients with knee osteoarthritis[J]. Exp Gerontol, 2017, 93:68-72.
|
| [28] |
Zhang Q, Zhang T. Effect on pain and symptoms of aspiration before hyaluronan injection for knee osteoarthritis: a prospective, randomized, single-blind study[J]. Am J Phy Med Rehabil, 2016, 95(5):366-371.
|
| [29] |
Maricar N, Callaghan MJ, Felson DT, et al. Predictors of response to intra-articular steroid injections in knee osteoarthritis－－a systematic review[J]. Rheumatology (Oxford), 2013, 52(6):1022-1032.
|
| [30] |
Kung J, Miller RR, Mackowiak PA. Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress[J]. Arch Intern Med, 2012, 172(21):1628-1633.
|
| [31] |
Brouwers MC, Kerkvliet K, Spithoff K. The AGREE reporting checklist：a tool to improve reporting of clinical practice guidelines[J/OL], 2016:i1152. doi: 10.1136/bmj.i1152 |
| [32] |
Sinclair D, Isba R, Kredo T, et al. World Health Organization guideline development: an evaluation[J/OL]. PLoS One, 2013, 8(5):e63715. doi： 10.1371/journal.pone.0063715 |
| [33] |
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR：a measurement tool to assess the methodological quality of systematic reviews[J/OL]. BMC Med Res Methodol. 2007, 7:10. doi： 10.1186/1471-2288-7-10 |
| [34] |
Higgins JP, Altman DG, Gøtzsche PC, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials[J/OL]. BMJ, 2011, 343:d5928. doi: 10.1136/bmj.d5928. |
| [35] |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25(9):603-605.
|
| [36] |
Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE Working Group[J/OL]. BMC Health Serv Res, 2004, 4(1):38. doi： 10.1186/1472-6963-4-38. |